(2S)-N-[(2S)-1-[4-[(6aS)-3-[3-[[(6aS)-8-(4-methoxyphenyl)-2-methyl-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]-2-(3-ethoxypropanoylamino)-3-methylbutanamide

C55H61N7O10 — CID 159765306

IUPAC(2S)-N-[(2S)-1-[4-[(6aS)-3-[3-[[(6aS)-8-(4-methoxyphenyl)-2-methyl-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]-2-(3-ethoxypropanoylamino)-3-methylbutanamide
SMILESCCOCCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)Nc1ccc(C2=CN3C(=O)c4cc(OC)c(OCCCOc5cc6c(cc5C)C(=O)N5C=C(c7ccc(OC)cc7)C[C@H]5C=N6)cc4N=C[C@@H]3C2)cc1)C(C)C
InChIInChI=1S/C55H61N7O10/c1-8-70-21-18-50(63)60-51(32(2)3)53(65)58-34(5)52(64)59-39-14-10-35(11-15-39)37-23-41-29-57-46-27-49(48(69-7)25-44(46)55(67)62(41)30-37)72-20-9-19-71-47-26-45-43(22-33(47)4)54(66)61-31-38(24-40(61)28-56-45)36-12-16-42(68-6)17-13-36/h10-17,22,25-32,34,40-41,51H,8-9,18-21,23-24H2,1-7H3,(H,58,65)(H,59,64)(H,60,63)/t34-,40-,41-,51-/m0/s1
InChIKeyBGPIIZFVWHEINJ-MXOLPHDWSA-N
MW980.13 g/mol
LogP7.81
Rot. Bonds20

About (2S)-N-[(2S)-1-[4-[(6aS)-3-[3-[[(6aS)-8-(4-methoxyphenyl)-2-methyl-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]-2-(3-ethoxypropanoylamino)-3-methylbutanamide

(2S)-N-[(2S)-1-[4-[(6aS)-3-[3-[[(6aS)-8-(4-methoxyphenyl)-2-methyl-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]-2-(3-ethoxypropanoylamino)-3-methylbutanamide (PubChem CID 159765306) has the molecular formula C55H61N7O10 and a molecular weight of 980.13 g/mol. Its IUPAC name is (2S)-N-[(2S)-1-[4-[(6aS)-3-[3-[[(6aS)-8-(4-methoxyphenyl)-2-methyl-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]-2-(3-ethoxypropanoylamino)-3-methylbutanamide.

Molecular Properties

Compound Name(2S)-N-[(2S)-1-[4-[(6aS)-3-[3-[[(6aS)-8-(4-methoxyphenyl)-2-methyl-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]-2-(3-ethoxypropanoylamino)-3-methylbutanamide
PubChem CID159765306
Molecular FormulaC55H61N7O10
Molecular Weight980.13 g/mol
Exact Mass979.45
IUPAC Name(2S)-N-[(2S)-1-[4-[(6aS)-3-[3-[[(6aS)-8-(4-methoxyphenyl)-2-methyl-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]-2-(3-ethoxypropanoylamino)-3-methylbutanamide
SMILESCCOCCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)Nc1ccc(C2=CN3C(=O)c4cc(OC)c(OCCCOc5cc6c(cc5C)C(=O)N5C=C(c7ccc(OC)cc7)C[C@H]5C=N6)cc4N=C[C@@H]3C2)cc1)C(C)C
InChIInChI=1S/C55H61N7O10/c1-8-70-21-18-50(63)60-51(32(2)3)53(65)58-34(5)52(64)59-39-14-10-35(11-15-39)37-23-41-29-57-46-27-49(48(69-7)25-44(46)55(67)62(41)30-37)72-20-9-19-71-47-26-45-43(22-33(47)4)54(66)61-31-38(24-40(61)28-56-45)36-12-16-42(68-6)17-13-36/h10-17,22,25-32,34,40-41,51H,8-9,18-21,23-24H2,1-7H3,(H,58,65)(H,59,64)(H,60,63)/t34-,40-,41-,51-/m0/s1
InChIKeyBGPIIZFVWHEINJ-MXOLPHDWSA-N
XLogP7.81
TPSA198.79 Ų
H-Bond Donors3
H-Bond Acceptors12
Rotatable Bonds20
Heavy Atoms72
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500980.13
LogP ≤ 57.81
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze (2S)-N-[(2S)-1-[4-[(6aS)-3-[3-[[(6aS)-8-(4-methoxyphenyl)-2-methyl-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]-2-(3-ethoxypropanoylamino)-3-methylbutanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S)-N-[(2S)-1-[4-[(6aS)-3-[3-[[(6aS)-8-(4-methoxyphenyl)-2-methyl-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]-2-(3-ethoxypropanoylamino)-3-methylbutanamide?
The IUPAC name of (2S)-N-[(2S)-1-[4-[(6aS)-3-[3-[[(6aS)-8-(4-methoxyphenyl)-2-methyl-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]-2-(3-ethoxypropanoylamino)-3-methylbutanamide (CID 159765306) is (2S)-N-[(2S)-1-[4-[(6aS)-3-[3-[[(6aS)-8-(4-methoxyphenyl)-2-methyl-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]-2-(3-ethoxypropanoylamino)-3-methylbutanamide.
What is the SMILES notation for (2S)-N-[(2S)-1-[4-[(6aS)-3-[3-[[(6aS)-8-(4-methoxyphenyl)-2-methyl-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]-2-(3-ethoxypropanoylamino)-3-methylbutanamide?
The canonical SMILES for (2S)-N-[(2S)-1-[4-[(6aS)-3-[3-[[(6aS)-8-(4-methoxyphenyl)-2-methyl-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]-2-(3-ethoxypropanoylamino)-3-methylbutanamide is CCOCCC(=O)N[C@H](C(=O)N[C@@H](C)C(=O)Nc1ccc(C2=CN3C(=O)c4cc(OC)c(OCCCOc5cc6c(cc5C)C(=O)N5C=C(c7ccc(OC)cc7)C[C@H]5C=N6)cc4N=C[C@@H]3C2)cc1)C(C)C.
What is the InChIKey of (2S)-N-[(2S)-1-[4-[(6aS)-3-[3-[[(6aS)-8-(4-methoxyphenyl)-2-methyl-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]-2-(3-ethoxypropanoylamino)-3-methylbutanamide?
The InChIKey is BGPIIZFVWHEINJ-MXOLPHDWSA-N. The full InChI is InChI=1S/C55H61N7O10/c1-8-70-21-18-50(63)60-51(32(2)3)53(65)58-34(5)52(64)59-39-14-10-35(11-15-39)37-23-41-29-57-46-27-49(48(69-7)25-44(46)55(67)62(41)30-37)72-20-9-19-71-47-26-45-43(22-33(47)4)54(66)61-31-38(24-40(61)28-56-45)36-12-16-42(68-6)17-13-36/h10-17,22,25-32,34,40-41,51H,8-9,18-21,23-24H2,1-7H3,(H,58,65)(H,59,64)(H,60,63)/t34-,40-,41-,51-/m0/s1.
What are the key properties of (2S)-N-[(2S)-1-[4-[(6aS)-3-[3-[[(6aS)-8-(4-methoxyphenyl)-2-methyl-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]-2-(3-ethoxypropanoylamino)-3-methylbutanamide?
(2S)-N-[(2S)-1-[4-[(6aS)-3-[3-[[(6aS)-8-(4-methoxyphenyl)-2-methyl-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]-2-(3-ethoxypropanoylamino)-3-methylbutanamide has a molecular weight of 980.13 g/mol, XLogP of 7.81, 20 rotatable bonds, 3 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-N-[(2S)-1-[4-[(6aS)-3-[3-[[(6aS)-8-(4-methoxyphenyl)-2-methyl-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]-2-(3-ethoxypropanoylamino)-3-methylbutanamide is sourced from PubChem (CID 159765306), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).